Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke

2015 ◽  
Vol 350 (1-2) ◽  
pp. 1-6 ◽  
Author(s):  
Andrea Santamato ◽  
Maria Francesca Micello ◽  
Maurizio Ranieri ◽  
Giovanni Valeno ◽  
Antonio Albano ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Higher Doses

scholarly journals Efficiency of Different Preparations of Botulinum Toxin Type A, Xeomin and Dysport, in the Management of Spastic Upper Limb After Stroke

2019 ◽  
Vol 70 (10) ◽  
pp. 3490-3494
Keyword(s):  
Botulinum Toxin ◽  
Upper Limb ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Local Effect ◽  
National Agency ◽  
Good Efficiency ◽  
Upper Limb Function ◽  
Higher Doses

The present study quantifies the effect of the two botulinum toxin type A products, Xeomin and Dysport, with approval from the National Agency for Medicines and Medical Devices of Romania (ANMDMR), for the treatment of the spastic upper limb following a stroke. The results obtained in the present study show a good efficiency of using both products in the spasticity of the upper limb, and a maintenance of the results obtained for both products for a minimum period of 3 months. Also, at higher doses, the results of the study show better improvement of spasticity and upper limb function on the evaluation scales, but the local effect is not maintained for a longer period. Keywords: toxinum botulinum type A, Xeomin, Dysport, spasticity

Efficiency of Different Preparations of Botulinum Toxin Type A, Xeomin and Dysport, in the Management of Spastic Upper Limb After Stroke

2019 ◽  
Vol 70 (10) ◽  
pp. 3490-3494
Author(s):  
Marius Nicolae Popescu ◽  
Razvan Cosmin Petca ◽  
Cristina Beiu ◽  
Mihai Cristian Dumitrascu ◽  
Aida Petca ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Upper Limb ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Local Effect ◽  
National Agency ◽  
Good Efficiency ◽  
Upper Limb Function ◽  
Higher Doses

The present study quantifies the effect of the two botulinum toxin type A products, Xeomin and Dysport, with approval from the National Agency for Medicines and Medical Devices of Romania (ANMDMR), for the treatment of the spastic upper limb following a stroke. The results obtained in the present study show a good efficiency of using both products in the spasticity of the upper limb, and a maintenance of the results obtained for both products for a minimum period of 3 months. Also, at higher doses, the results of the study show better improvement of spasticity and upper limb function on the evaluation scales, but the local effect is not maintained for a longer period.

Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke

2012 ◽  
Vol 120 (3) ◽  
pp. 469-476 ◽  
Author(s):  
Andrea Santamato ◽  
Francesco Panza ◽  
Maurizio Ranieri ◽  
Vincenza Frisardi ◽  
Maria Francesca Micello ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Lower Limb ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Efficacy And Safety ◽  
Nt 201 ◽  
Limb Spasticity ◽  
Lower Limb Spasticity ◽  
Higher Doses

Botulinum Toxin Type A Therapy in Chronic Headache Patients

2005 ◽  
Vol 18 (1) ◽  
pp. 29
Author(s):  
Dong Eon Moon ◽  
Young Eun Moon ◽  
Shi Hyeon Kim ◽  
Eun Sung Kim
Keyword(s):  
Botulinum Toxin ◽  
Chronic Headache ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Headache Patients
Sign in / Sign up

Export Citation Format

Share Document